CervoMed Inc. (NASDAQ: CRVO) Stock Information | RedChip

CervoMed Inc. (NASDAQ: CRVO)


$2.3200
+0.0900 ( +5.46% ) 166.7K

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Market Data


Open


$2.3200

Previous close


$2.2300

Volume


166.7K

Market cap


$17.83M

Day range


$2.1450 - $2.3470

52 week range


$1.8000 - $26.3789

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Aug 27, 2024
8-k 8K-related 16 Aug 15, 2024
10-q Quarterly Reports 71 Aug 09, 2024
8-k 8K-related 17 Aug 01, 2024
8-k 8K-related 14 Jul 23, 2024
8-k 8K-related 15 Jul 12, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024

Latest News